| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
William Chung, Kevin Wong, Noel Ravindranayagam, Lauren Tang, Josephine Grace, Darren Wong, Danny Con, Marie Sinclair, Avik Majumdar, Numan Kutaiba, Samuel Hui, Paul Gow, Vijayaragavan Muralidharan, Alexander Dobrovic and Adam Testro |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
William Chung, FRACP, MBBS, Attending Doctor, Doctor, Doctor, Research Fellow, Staff Physician, Department of Gastroenterology, Austin Health, No. 145 Studley Road, Heidelberg 3084, Victoria, Australia. william.chung2@austin.org.au |
| Key Words |
Liver transplantation; Hepatocellular carcinoma; Transplant oncology; Statins; HMG-Co-A reductase; Aspirin; Metformin; Mammalian target of rapamycin |
| Core Tip |
In this single centre, retrospective study of adult patients who received liver transplantation (LT) for Hepatocellular carcinoma in Australia, statin, aspirin or metformin use after LT was not associated with a difference in the composite endpoint of hepatocellular carcinoma (HCC)-recurrence and all-cause mortality, HCC-recurrence or HCC-related mortality. |
| Publish Date |
2024-07-31 07:20 |
| Citation |
<p>Chung W, Wong K, Ravindranayagam N, Tang L, Grace J, Wong D, Con D, Sinclair M, Majumdar A, Kutaiba N, Hui S, Gow P, Muralidharan V, Dobrovic A, Testro A. Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective study. <i>World J Transplant</i> 2024; 14(3): 94914</p> |
| URL |
https://www.wjgnet.com/2220-3230/full/v14/i3/94914.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v14.i3.94914 |
